ViraEpi983 | Epstein barr virus (EBV) | Cp | NA | 11063 | 11063 | Intermediate | 60% | Spleen | Frozen spleen samples from patients | 5 samples from patient 1 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi988 | Epstein barr virus (EBV) | Cp | NA | 11146 | 11146 | Intermediate | 0% | Spleen | Frozen spleen samples from patients | 5 samples from patient 1 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi1000 | Epstein barr virus (EBV) | Cp | NA | 10985 | 10985 | Intermediate | 60% | Spleen | Frozen spleen samples from patients | 5 samples from patient 2 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi1008 | Epstein barr virus (EBV) | Cp | NA | 11122 | 11122 | Intermediate | 60% | Spleen | Frozen spleen samples from patients | 5 samples from patient 2 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi1009 | Epstein barr virus (EBV) | Cp | NA | 11146 | 11146 | Intermediate | 60% | Spleen | Frozen spleen samples from patients | 5 samples from patient 2 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi1018 | Epstein barr virus (EBV) | Cp | NA | 11365 | 11365 | Intermediate | 60% | Spleen | Frozen spleen samples from patients | 5 samples from patient 2 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi1026 | Epstein barr virus (EBV) | Cp | NA | 11066 | 11066 | IntermedIate | 60% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi1031 | Epstein barr virus (EBV) | Cp | NA | 11171 | 11171 | IntermedIate | 60% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi1084 | Epstein barr virus (EBV) | Fp | NA | 62121 | 62121 | intermediate | 50% | Spleen | Frozen spleen sample from patient | 4 samples from patient 1 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | ViraEpi1169 | Epstein barr virus (EBV) | Fp | NA | 62104 | 62104 | Intermediate | 60% | PBMC | PBMC from patient | 5 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | ViraEpi1201 | Epstein barr virus (EBV) | Fp | NA | 62133 | 62133 | Intermediate | 50% | PBMC | PBMC from patient | 4 samples from patient 5 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | ViraEpi1241 | Epstein barr virus (EBV) | Cp | NA | 11198 | 11198 | Intermediate | 50% | Cell line | RAEL cell line | 4 clones | NA | Bisulphite PCR | 8972217 | ViraEpi1259 | Epstein barr virus (EBV) | Cp | NA | 11146 | 11146 | Intermediate | 50% | Cell line | NPC-KT cell line | 4 clones | NA | Bisulphite PCR | 8972217 | ViraEpi1262 | Epstein barr virus (EBV) | Cp | NA | 11198 | 11198 | Intermediate | 50% | Cell line | NPC-KT cell line | 4 clones | NA | Bisulphite PCR | 8972217 | ViraEpi1266 | Epstein barr virus (EBV) | Cp | NA | 11294 | 11294 | Intermediate | 50% | Cell line | NPC-KT cell line | 4 clones | NA | Bisulphite PCR | 8972217 | ViraEpi1280 | Epstein barr virus (EBV) | Cp | NA | 11146 | 11146 | Intermediate | 50% | Cell line | D98HR1 cell line | 4 clones | NA | Bisulphite PCR | 8972217 | ViraEpi1361 | Epstein barr virus (EBV) | Cp | NA | 10959 | 10959 | Intermediate | 66.66% | BL tumor sample 4 | Tumor from untreated patient | 6 clones | Burkitt Lymphoma (BL) | Bisulphite PCR | 8874213 | ViraEpi1363 | Epstein barr virus (EBV) | Cp | NA | 10988 | 10988 | Intermediate | 66.66% | BL tumor sample 4 | Tumor from untreated patient | 6 clones | Burkitt Lymphoma (BL) | Bisulphite PCR | 8874213 | ViraEpi1365 | Epstein barr virus (EBV) | Cp | NA | 11045 | 11045 | Intermediate | 66.66% | BL tumor sample 4 | Tumor from untreated patient | 6 clones | Burkitt Lymphoma (BL) | Bisulphite PCR | 8874213 | ViraEpi1370 | Epstein barr virus (EBV) | Cp | NA | 10959 | 10959 | Intermediate | 60% | BL tumor sample 5 | Tumor from untreated patient | 5 clones | Burkitt Lymphoma (BL) | Bisulphite PCR | 8874213 | ViraEpi1374 | Epstein barr virus (EBV) | Cp | NA | 11045 | 11045 | Intermediate | 60% | BL tumor sample 5 | Tumor from untreated patient | 5 clones | Burkitt Lymphoma (BL) | Bisulphite PCR | 8874213 | ViraEpi1377 | Epstein barr virus (EBV) | Cp | NA | 10866 | 10866 | Intermediate | 57.14% | HD tumor sample 1 | Tumor from untreated patient | 7 clones | Hodgkin disease (HD) | Bisulphite PCR | 8874213 | ViraEpi1380 | Epstein barr virus (EBV) | Cp | NA | 10985 | 10985 | Intermediate | 57.14% | HD tumor sample 1 | Tumor from untreated patient | 7 clones | Hodgkin disease (HD) | Bisulphite PCR | 8874213 | ViraEpi1381 | Epstein barr virus (EBV) | Cp | NA | 10988 | 10988 | Intermediate | 57.14% | HD tumor sample 1 | Tumor from untreated patient | 7 clones | Hodgkin disease (HD) | Bisulphite PCR | 8874213 | ViraEpi1382 | Epstein barr virus (EBV) | Cp | NA | 11030 | 11030 | Intermediate | 57.14% | HD tumor sample 1 | Tumor from untreated patient | 7 clones | Hodgkin disease (HD) | Bisulphite PCR | 8874213 |